These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 29360648

  • 1. Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach.
    Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Taverna F, Lombardo C, Borghi C, Scaffa C, Lorusso D, Raspagliesi F.
    Eur J Cancer Prev; 2019 Mar; 28(2):81-86. PubMed ID: 29360648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
    Nagai Y, Maehama T, Asato T, Kanazawa K.
    Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
    Fallani MG, Penna C, Marchionni M, Bussani C, Pieralli A, Andersson KL, Fambrini M.
    Eur J Gynaecol Oncol; 2008 Nov; 29(4):378-82. PubMed ID: 18714574
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
    Heymans J, Benoy IH, Poppe W, Depuydt CE.
    Int J Cancer; 2011 Aug 15; 129(4):903-9. PubMed ID: 21064091
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
    Kudoh A, Sato S, Itamochi H, Komatsu H, Nonaka M, Sato S, Chikumi J, Shimada M, Oishi T, Kigawa J, Harada T.
    Int J Clin Oncol; 2016 Jun 15; 21(3):580-7. PubMed ID: 26614089
    [Abstract] [Full Text] [Related]

  • 9. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.
    BJOG; 2006 Nov 15; 113(11):1303-7. PubMed ID: 16978225
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment.
    Venturoli S, Ambretti S, Cricca M, Leo E, Costa S, Musiani M, Zerbini M.
    J Med Virol; 2008 Aug 15; 80(8):1434-40. PubMed ID: 18551620
    [Abstract] [Full Text] [Related]

  • 12. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China.
    Hong D, Ye F, Chen H, Lü W, Cheng Q, Hu Y, Xie X.
    Int J Gynecol Cancer; 2008 Aug 15; 18(1):104-9. PubMed ID: 17466048
    [Abstract] [Full Text] [Related]

  • 13. The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS.
    Banović M, Mahovlić V, Salopek KM, Banović V, Babić I, Orešković S, Babić D.
    Pathol Oncol Res; 2015 Jul 15; 21(3):613-7. PubMed ID: 25432549
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Hammes LS, Branca M, Grunjberga V, Erzen M, Sarian LO, Juschenko A, Costa S, Podistov J, Syrjänen S, New Independent States of the Former Soviet Union and the Latin American Screening Study Research Groups.
    Int J Gynecol Cancer; 2009 Jul 15; 19(5):934-42. PubMed ID: 19574788
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
    Bogani G, Pinelli C, Chiappa V, Martinelli F, Lopez S, Ditto A, Raspagliesi F.
    J Gynecol Oncol; 2020 Sep 15; 31(5):e60. PubMed ID: 32808492
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
    Futai M, Watanabe J, Jobo T, Tsunoda S, Nishimura Y, Watanabe K, Okayasu I, Unno N.
    Int J Gynecol Cancer; 2009 Nov 15; 19(8):1396-401. PubMed ID: 20009896
    [Abstract] [Full Text] [Related]

  • 19. Development of in-house multiplex real time PCR for human papillomavirus genotyping in Iranian women with cervical cancer and cervical intraepithelial neoplasia.
    Sohrabi A, Mirab-Samiee S, Modarresi MH, Izadimood N, Azadmanesh K, Rahnamaye-Farzami M.
    Asian Pac J Cancer Prev; 2014 Nov 15; 15(15):6257-61. PubMed ID: 25124608
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.